top of page
News, Events and Updates
Search
Anavex Life Sciences Presents New Data Identifying Treatment Response Biomarkers in Alzheimer’s Dise
Jul 24, 2018
Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX®2-73
Jul 8, 2018
Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73
Jul 2, 2018
Anavex participates on Brain Health panel at Bio International Conference in Boston
Jun 4, 2018
Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results
May 9, 2018
Anavex Life Sciences to Announce Fiscal Second Quarter 2018 Financial Results on Thursday, 5/10/2018
May 8, 2018
Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX®2-73 in Parkinson's Disease Dementia
Apr 16, 2018
Anavex Life Sciences to Present at the 30th Annual ROTH Conference
Mar 9, 2018
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the ASENT
Mar 7, 2018
Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care Conference
Mar 6, 2018
Anavex Life Sciences Strengthens Management Team and Board of Directors
Mar 5, 2018
21
22
23
24
25
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
